Dr. Bryson William Katona, MD, PhD

Dr. Katona practices at Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Katona's NPI, 1841434339, was assigned on April 28, 2009. Dr. Katona graduated from Washington University School of Medicine in 2009. Dr. Katona holds Pennsylvania license MD445572.

Dr. Katona's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104. The practice phone is (215) 615-4949.

Dr. Katona's primary practice is Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania. Dr. Katona is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Katona to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katona practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Katona's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Katona is licensed in Pennsylvania.

CMS data shows 222 Medicare services from Dr. Katona across 8 procedure codes in 2024, for 143 Medicare patients. Medicare paid $15,812 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Dr. Katona in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katona's median patient age at 58, with 57% women.

In 2024, Dr. Katona wrote 49 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $27 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Katona for performance year 2024, reported as part of a group. Dr. Katona accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Katona, more than 53% of the clinicians it reports for that procedure.

Dmand AI links 116 papers to Dr. Katona, published from 2014 to 2025. 2022 was the busiest year, with 16. The most frequent topics are Genetic Predisposition to Disease, Pancreatic Neoplasms and Colorectal Neoplasms. Dr. Katona has published most often in Cancer Prev Res (Phila). Dr. Katona's most frequent co-authors are Randall E. Brand, Anil K. Rustgi, MD and David C. Metz, MD.

Dmand AI links Dr. Katona to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Colorectal Neoplasms, Colonic Neoplasms and Pancreatic carcinoma, familial.

CMS Open Payments shows 13 general payments to Dr. Katona from 5 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 54% of the total. Ipsen Innovation paid the most, $1,920.

Dr. Katona graduated from Washington University School of Medicine in 2009.